Wendy Brewster
#100,254
Most Influential Person Now
Professor of Obstetrics and Gynaecology
Wendy Brewster's AcademicInfluence.com Rankings
Wendy Brewsterphilosophy Degrees
Philosophy
#11514
World Rank
#15863
Historical Rank
Logic
#9351
World Rank
#11841
Historical Rank
Download Badge
Philosophy
Wendy Brewster's Degrees
- Doctorate Medicine Stanford University
- PhD Reproductive Biology Stanford University
Why Is Wendy Brewster Influential?
(Suggest an Edit or Addition)According to Wikipedia, Wendy Rosamund Brewster was a British-born American gynaecologist who was Professor of Obstetrics and Gynaecology and Director of the Center for Women's Health Research at the University of North Carolina at Chapel Hill.
Wendy Brewster's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies (2012) (738)
- A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 (2010) (341)
- A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2 (2009) (305)
- Common variants at 19p13 are associated with susceptibility to ovarian cancer (2010) (262)
- Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound Consensus Conference Statement. (2010) (258)
- Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer. (2019) (182)
- Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus (2000) (156)
- Management of asymptomatic ovarian and other adnexal cysts imaged at US Society of Radiologists in Ultrasound consensus conference statement. (2010) (116)
- DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2014) (112)
- The use of hypothermia in surgical treatment of cerebral vascular lesions; a preliminary report. (1955) (103)
- Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials (2017) (95)
- Stages III and IV Invasive Epithelial Ovarian Carcinoma in Younger Versus Older Women: What Prognostic Factors Are Important? (2003) (88)
- ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study (2010) (88)
- Racial disparity in survival among patients with advanced/recurrent endometrial adenocarcinoma (2006) (88)
- A randomized controlled trial of the effect of increased intravenous hydration on the course of labor in nulliparous women. (2000) (88)
- Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. (2001) (83)
- Signet Ring Cell Histology is Associated with Unique Clinical Features but Does Not Affect Gastric Cancer Survival (1999) (71)
- Breast Cancer Survival and Hormone Replacement Therapy: A Cohort Analysis (2000) (67)
- Translational Studies of Phenotypic Probes for the Mononuclear Phagocyte System and Liposomal Pharmacology (2013) (66)
- Large Prospective Study of Ovarian Cancer Screening in High-Risk Women: CA125 Cut-Point Defined by Menopausal Status (2011) (57)
- The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing (2011) (56)
- Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. (2009) (53)
- A Genome-Wide Association Study Identifies A New Ovarian Cancer Susceptibility Locus On 9 p 22 . 2 (2010) (50)
- A Randomized, Double Blind, Phase III Trial Using Oral β-Carotene Supplementation for Women with High-Grade Cervical Intraepithelial Neoplasia (2001) (48)
- Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium (2009) (45)
- Interstitial brachytherapy for vaginal recurrences of endometrial carcinoma. (1999) (44)
- Recruitment strategies for cervical cancer prevention study. (2002) (41)
- A Phase 3 Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High-Risk, Early-Stage Endometrial Cancer: A Gynecology Oncology Group Study (2017) (37)
- Simple Adnexal Cysts: SRU Consensus Conference Update on Follow-up and Reporting. (2019) (36)
- Disparities in the Allocation of Treatment in Advanced Ovarian Cancer: Are There Certain Patient Characteristics Associated With Nonstandard Therapy? (2012) (34)
- Day-3 embryo morphology predicts euploidy among older subjects. (2008) (34)
- The Topography of Colorectal Cancer Varies by Race/Ethnicity and Affects the Utility of Flexible Sigmoidoscopy (2001) (32)
- Outpatient end of life discussions shorten hospital admissions in gynecologic oncology patients. (2013) (32)
- A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia. (2001) (32)
- Young age as a prognostic factor in cervical cancer: results of a population-based study. (1999) (30)
- Preoperative quality of life and surgical outcomes in gynecologic oncology patients: a new predictor of operative risk? (2014) (30)
- Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial. (2005) (30)
- Intent‐to‐Treat Analysis of Stage Ib and IIa Cervical Cancer in the United States: Radiotherapy or Surgery 1988–1995 (2001) (29)
- Evaluating the urban-rural paradox: The complicated relationship between distance and the receipt of guideline-concordant care among cervical cancer patients. (2019) (25)
- Differentiating Squamous Cell Carcinoma of the Cervix and Epithelioid Trophoblastic Tumor (2011) (23)
- Technetium Tc 99m sulfur colloid phenotypic probe for the pharmacokinetics and pharmacodynamics of PEGylated liposomal doxorubicin in women with ovarian cancer (2016) (22)
- An experience with estrogen replacement therapy in breast cancer survivors. (1999) (21)
- Polymorphism in the IL18 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women (2008) (21)
- Association of Preoperative Thrombocytosis and Leukocytosis With Postoperative Morbidity and Mortality Among Patients With Ovarian Cancer (2015) (20)
- p16-Positive Small Cell Neuroendocrine Carcinoma of the Endometrium (2006) (19)
- A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer. (2009) (18)
- Does the ALTS trial apply to the community-based practitioner? (2003) (17)
- Examining Urban and Rural Differences in How Distance to Care Influences the Initiation and Completion of Treatment among Insured Cervical Cancer Patients (2019) (17)
- Did GOG99 and PORTEC1 change clinical practice in the United States? (2013) (16)
- Gynecologic oncologists involvement on ovarian cancer standard of care receipt and survival (2016) (16)
- Hormone replacement therapy in breast cancer survivors. (2000) (16)
- For U.S. Black women, shift of hysterectomy to outpatient settings may have lagged behind White women: a claims-based analysis, 2011–2013 (2017) (15)
- Gender and race/ethnicity affect the cost-effectiveness of colorectal cancer screening. (2006) (15)
- Does human papillomavirus have a role in cancers of the uterine corpus? (1999) (15)
- Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium (2009) (13)
- Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare, Medicaid, and privately insured women. (2016) (13)
- Dynamic cervical change during real‐time ultrasound: prospective characterization and comparison in patients with and without symptoms of preterm labor (2004) (11)
- An evaluation of the microbiota of the upper genital tract of women with benign changes and epithelial ovarian cancer. (2016) (11)
- Population characteristics in cervical cancer trials: search for external validity. (2005) (10)
- Clinical Benefits Associated With Medicaid Coverage Before Diagnosis of Gynecologic Cancers. (2016) (10)
- Socioeconomic factors may contribute to neoadjuvant chemotherapy use in metastatic epithelial ovarian carcinoma. (2009) (8)
- Epithelial Ovarian Cancer and Low Malignant Potential (LMP) Tumors Associated With a Lower Incidence of Second Primary Breast Cancer (2007) (7)
- Differences in the microbial profiles of early stage endometrial cancers between Black and White women. (2022) (7)
- DNA methylation of imprinted gene control regions in the regression of low‐grade cervical lesions (2018) (7)
- A prospective multi-center ovarian cancer screening study in women at increased risk (2007) (5)
- Impact of obesity on the uterine and gut microbiome in postmenopausal mice with and without endometrial cancer (2020) (5)
- Temporal trends in ovarian cancer: incidence and mortality across Europe (2005) (5)
- Alterations in the uterine microbiome in patients with early endometrial cancer: Variations by ethnicity and obesity. (2017) (4)
- Obesity, diabetes, and race in Type 1 and Type 2 endometrial cancers. (2011) (4)
- Correction: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer (2016) (4)
- Hormone replacement therapy for survivors of breast and endometrial cancer (2002) (4)
- The complexity of race in the disparate outcome and treatment of minority patients. (2008) (4)
- Impact of ethnicity and obesity on the uterine microbiome in women and mice with endometrial cancer (2019) (4)
- An evaluation of the microbiota of the upper reproductive tract of women with and without epithelial ovarian cancer (2022) (4)
- Preoperative thrombocytosis and leukocytosis among ovarian cancer patients are associated with postoperative death (2015) (3)
- Society of Gynecologic Oncology 2018 Annual Meeting on Women's Cancer: Meeting report. (2018) (3)
- Cellular function of the mononuclear phagocyte system (MPS) as a phenotypic probe for pharmacokinetics (PK) and pharmacodynamics (PD) of PEGylated liposomal doxorubicin (PLD) in patients with recurrent ovarian cancer. (2012) (2)
- Technetium-99m sulfur colloid (TSC) as a phenotypic probe for predicting pharmacokinetics (PK) and palmar-plantar erythrodysesthesia (PPE) toxicity of pegylated liposomal doxorubicin (PLD) in patients (pts) with recurrent epithelial ovarian cancer (EOC). (2012) (2)
- Discussion: 'Surgical staging in early ovarian carcinoma' by Garcia-Soto et al. (2012) (2)
- Erratum: Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium (British Journal of Cancer (2009) 100 (412-420) DOI: 10.1038/sj.bjc.6604820 www.bjcancer.com) (2009) (2)
- Cellular function of the mononuclear phagocyte system (MPS) as a phenotypic probe for pegylated liposomal doxorubicin (PLD) pharmacokinetics (PK) in patients with recurrent ovarian cancer. (2011) (2)
- The impact of outpatient hospice discussions on subsequent inpatient hospitalization in gynecologic oncology patients (2013) (1)
- Abstract 2673: Relationship between serum hormone levels and pharmacokinetics (PK) of PEGylated liposomal doxorubicin (PLD) in patients with refractory ovarian cancer (2012) (1)
- Society of Gynecologic Oncology 2018 Annual Meeting on Women's Cancer: Meeting report (2018) (1)
- 187 Fetal pulse oximetry: Defining which variable decelerations with slow return to baseline are associated with hypoxia (2001) (1)
- Cardiovascular disease diagnoses among older women with endometrial cancer. (2022) (1)
- 15.: Estrogen Replacement Therapy in Breast Cancer Survivors (1997) (1)
- Have PORTEC 1 and GOG 99 changed practice patterns in the United States (2011) (1)
- Untreated cervical cancer. (2005) (1)
- Breast Cancer Survival and Hormone Replacement Therapy (2000) (1)
- 633 Cervical dynamicism: Comparison of real-time cervical shortening with transfundal pressure measurements (2001) (0)
- IS HORMONE REPLACEMENT THERAPY SAFE IN BREAST CANCER SURVIVORS. AUTHORS' REPLY (1997) (0)
- Epidemiology of Commonly Used Statistical Terms, and Analysis of Clinical Studies (2007) (0)
- Technetium-99m sulfur colloid (TSC) as a phenotypic probe for the pharmacokinetics (PK) and pharmacodynamics (PD) of pegylated liposomal doxorubicin (PLD) in patients (pts) with recurrent epithelial ovarian cancer (EOC). (2011) (0)
- Abstract 4462: The effects of NT-1044, a novel AMPK activator, on endometrial cancer cell proliferation and apoptosis (2015) (0)
- Surgical staging in early ovarian carcinoma: Garcia-Soto et al (2012) (0)
- Oral contraceptive use and risk of ovarian cancer in women with a family history of cancer (1999) (0)
- Does the Robotic Platform Overcome Hand Dominance in Gynecologic Surgeons (2013) (0)
- Patient characteristics and health system factors associated with adjuvant radiation therapy receipt in older women with early-stage endometrial cancer. (2022) (0)
- 184 Late decelerations and severe variables are predictive of fetal hypoxia (2001) (0)
- A Randomized, Double Blind, Phase III Trial Using Oral (cid:1) -Carotene Supplementation for Women with High-Grade Cervical Intraepithelial Neoplasia 1 (2001) (0)
- Extended human papillomavirus genotyping to predict progression to high-grade cervical precancer: A prospective cohort study in the southeastern United States. (2022) (0)
- Hormone replacement therapy in gynecologic cancer patients and survivors (2004) (0)
- Recruitment Strategies for Cervical Cancer Prevention Study 1 (2002) (0)
- Preoperative quality of life in gynecologic oncology patients: A new predictor of operative risk? (2014) (0)
- Alterations in the uterine microbiome in women and mice with endometrial cancer: Variations by race and obesity (2018) (0)
- Adverse urinary system diagnoses among older women with endometrial cancer. (2022) (0)
- REPRODUCTIVE AGE WOMEN WITH STAGE III AND IV INVASIVE EPITHELIAL OVARIAN CARCINOMA: A COMPARATIVE STUDY (2003) (0)
- Comparison of tumor microbiota between primary and recurrent or metastatic sites in women with advanced or relapsed endometrial and ovarian cancer (240) (2022) (0)
- Noninvasive Serous Papillary Carcinoma of the Endometrium: What Is the Appropriate Staging Surgery? (2003) (0)
- A Comparative Study of Younger and Older Women With Stage III and IV Invasive Ovarian Carcinoma (2003) (0)
- Limited dose external beam irradiation and interstitial iridium 192 implant in definitive treatment of carcinoma of the oropharynx. Long term results (2001) (0)
- Trainee participation in surgery for ovarian cancer: Impact on patient outcomes (2015) (0)
- Chapter 23 – Epidemiology of Commonly Used Statistical Terms, and Analysis of Clinical Studies (2007) (0)
- O-15: Does Preimplantation Genetic Diagnosis Correlate With Day-3 Embryo Morphology? (2006) (0)
- Biomarker Profiles and Cytoplasmic Vacuolization as Predictors of Progression-Free Survival and Clinical Response to Neoadjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer (2007) (0)
- Hybrid models of care between high and low volume centers and associations with uterine cancer treatment and survival (2016) (0)
- Multi-level determinants of endometrial cancer diagnosis as experienced by Black women. (2022) (0)
- Socioeconomic factors may contribute to the poor prognosis observed among women with advanced ovarian carcinoma treated with neoadjuvant chemotherapy (2008) (0)
- P-25: The Predictive Value of Embryo Developmental Rate for PGD Results and Pregnancy Outcomes (2006) (0)
- Obesity-driven microbial and metabolic changes with cytotoxic chemotherapy in the LKB1fl/flp53fl/fl genetically engineered mouse model of endometrioid endometrial cancer (2021) (0)
- Insurance and adherence to guideline concordant cervical cancer therapy do not reduce mortality? (2020) (0)
- University of Groningen DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers Osorio, (2014) (0)
- Should colorectal cancer screening guidelines account for gender and race/ethnicity? (2004) (0)
- Abstract PR07: Impact of race on the uterine microbiome in women with early stage endometrial cancer (2020) (0)
- Beneficial involvement of gynecologic oncologist in Medicare ovarian cancer patient's standard of care treatment receipt and survival. (2015) (0)
- Abstract B29: Impact of obesity on the uterine microbiome in pre- and postmenopausal mice with endometrial cancer (2020) (0)
- The effect of pretreatment patient characteristics on the allocation of treatment for advanced epithelial ovarian cancer. (2016) (0)
- Education Forum V: Global Challenges in Gynecologic Oncology Care (2014) (0)
- Demographic and clinical factors associated with variations in opioid administration using conscious sedation during HDR brachytherapy for cervical cancer. (2021) (0)
- The association of pretreatment patient characteristics on the allocation of treatment in stage II ovarian cancer. (2009) (0)
- 185 All non-reactive fetal heart rate tracings are not equal (2001) (0)
- Adjuvant radiation therapy and health-related quality of life among older women with early-stage endometrial cancer: an analysis using the SEER-MHOS linkage (2022) (0)
- Summary of the 2011 Annual Meeting on Women's Cancers. (2011) (0)
- Sex Cord Stromal Ovarian Cancers: Survival and Recurrence Prognostic Factors (2003) (0)
- Could a pelvic and abdominal symptom index assist in early detection of ovarian cancer? (2007) (0)
- The association of Medicaid coverage status at the time of cancer diagnosis in women with gynecologic malignancies: A population-based study (2015) (0)
- Geographic variation in high-risk uterine cancer histology and access to care. (2014) (0)
- 68 Cervical dynamicism: Definition and incidence in preterm patients with and without preterm labor symptoms (2001) (0)
- Chapter 22 – Epidemiology of Commonly Used Statistical Terms and Analysis of Clinical Studies (2012) (0)
- Gynecologic cancer outcomes of Medicare's elderly poor: A population-based study of North Carolina. (2014) (0)
- 186 The effect of maternal age on standardized cesarean section rates (2001) (0)
- 632 Cervical dynamicism: Comparison of real-time cervical shortening with uterine activity (2001) (0)
- Abstract 2230: Extended human papillomavirus genotyping to predict progression to high-grade cervical precancer: A prospective cohort study in the southeastern United States (2022) (0)
- Adverse Urinary System Outcomes among Older Women with Endometrial Cancer. (2022) (0)
- Abstract 3084: The effects of NT-1044, a novel AMPK activator, on endometrial cancer cell proliferation, apoptosis, cell stress, and tumor growth (2016) (0)
- Current standards of breast cancer treatment in the USA (1997) (0)
This paper list is powered by the following services:
Other Resources About Wendy Brewster
What Schools Are Affiliated With Wendy Brewster?
Wendy Brewster is affiliated with the following schools:
